December 2006
Worldwide Biotech;Dec2006, Vol. 18 Issue 12, p8
Trade Publication
The article reports on a marketing authorization for Etopan XL Tablets, Etodolac granted by the Medicines and Healthcare Products Regulatory Agency of Great Britain to Taro Pharmaceutical Industries Ltd. According to Samuel Rubinstein, senior vice president and general manager of Taro, the introduction of Etopan XL represents a significant addition to their product portfolio in Great Britain.


Related Articles

  • Depressing Seroxat decision for GlaxoSmithKline.  // PharmaWatch: CNS;August 2003, Vol. 2 Issue 8, p27 

    Reports on the risks associated with Seroxat, an antidepressant drug manufactured by GlaxoSmithkline PLC in Great Britain. Cases of suicide reported after treatment using the drug; Reaction of GlaxoSmithkline on the action of the British Medicines and Healthcare Products Regulatory Agency...

  • 'Grave concern' over new OTC drive. Kelly, Brian // Pulse;8/9/2004, Vol. 64 Issue 32, p4 

    The article focuses on Government plans of Great Britain to accelerate the OTC revolution. The Medicines and Healthcare Products Regulatory Agency (MHRA) has released proposals for a data protection deal to make it far more profitable for drug firms to reclassify products as OTC, by offering...

  • BUST THE DRUGS CLUB.  // Community Care;10/21/2004, Issue 1545, p5 

    Comments on the proposal to manage Great Britain's Medicines and Healthcare Products Regulatory Agency by representatives of the pharmaceutical industry. Disadvantages of the proposal; Suggested changes in the agency.

  • BPH and chlamydia drugs to go OTC.  // Pulse;8/24/2006, Vol. 66 Issue 33, p2 

    The article reports that a drug for the treatment of benign prostatic hyperplasia and an antibiotic for chlamydia are to be made available over the counter in Great Britain. The Medicines and Healthcare Products Regulatory Agency has announced plans to consider the drugs as part of a continuing...

  • Research & Development Update.  // PharmaWatch: Cancer;May2006, Vol. 5 Issue 5, p4 

    The article reports on developments related to the pharmaceutical industry. The Bristish Medicines and Health Products Regulatory Agency has released its report into the adverse results of the trial made by the TeGenero AG. SGX Pharmaceuticals has signed a $515 million deal with Novartis AG for...

  • Co-proxamol to be withdrawn in the UK.  // Reactions Weekly;2/5/2005, Issue 1037, p2 

    Reports on the announcement made by UK Medicines and Healthcare products Regulatory Agency regarding a phased market withdrawal of co-proxamol over the next 6-12 months in Great Britain. Purpose of the letter written by Professor Gordon Duff, chairman of the Committee on Safety of Medicines...

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;11/22/2008, Issue 1229, p3 

    This section offers news briefs related to the pharmaceutical industry in Great Britain. The Medicines and Healthcare products Regulatory Agency (MHRA) has advised consumers not to use Melanotan, synthetic analogs of peptide hormone alpha-melanocyte stimulating hormone (MSH), which is being sold...

  • Will Seroxat scandal damage GSK?  // PRWeek (London);3/28/2008, p15 

    The article discusses the impact on the reputation of pharmaceutical company GlaxoSmithKline (GSK) of a scandal involving its product Seroxat. The UK Medicines and Healthcare Products Regulatory Authority had found that early clinical trials showed that the drug caused an increased risk of...

  • Fake drugs spark supply chain criminal probe.  // Pharmaceutical Technology Europe;Jul2007, Vol. 19 Issue 7, p6 

    The article reports that the Medicines and Healthcare Products Regulatory Agency (MRHA) has been alerted to several counterfeit products in Great Britain. The agency has launched a criminal investigation regarding the issue, has issued five drug alerts, recalling counterfeit batches of Zyprexa,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics